A look at how targeted peptides taken by mouth can survive the gut and still reach specific sites in the body. Details are in the full story.
Recap by typeshit. Post by The Kansas City Star on X.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
Researchers are working on peptides that can withstand the gut and target specific cells. That could open a path to more precise prescription pills.
Dr. Lorenc says patients ask him about peptides every week, and he pushes back on the idea that buzz on social feeds means the evidence is there.
Loading…